SlideShare uma empresa Scribd logo
1 de 1
HIV Testing Practices Among Providers in Washington D.C.
Sofija Degesys, BA1; Isla McClelland, BS1; Christina Hanna, BS1; Kyle Bunker,BS1;
Mary Beth Levin, MPH1; Eileen Moore, MD2
Abstract
1Georgetown University School of Medicine, Washington, DC; 2Department of Medicine, Georgetown University Hospital, Washington,
Introduction
Methods
Conclusions
References
Acknowledgments
Georgetown University
1. Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria. Why Aren’t D.C. Doctors Testing for HIV? 2010 Nov 17 <http://www.gbcimpact.org/node/2897>.
2. District of Columbia Department of Health. The District of Columbia HIV/AIDS Epidemiology 2008 Update.
3. District of Columbia Department of Health and George Washington University School of Public Health and Health Services. District of Columbia HIV/AIDS Behavioral Surveillance Summary Report 2008.
4. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings. MMWR Morb Moral Wkly Rep. 2006 Sep 22.
Results and Discussion
Both the D.C. Department of Health (DOH) and the CDC recommend providers use opt-
out HIV testing for all adults, adolescents and pregnant patients. Unfortunately, lack of
adherence to these recommendations can have serious consequences as patients
unaware of their HIV status will have later diagnoses, correlating with worse medical
outcomes. It also leads to the unwitting transmission of HIV to others. A survey was
distributed through 520 Georgetown medical students to providers in the D.C. area. The
goal of this survey is to assess provider practices, knowledge of guidelines and
perceived barriers to routine HIV testing, as well as creating an opportunity for students
to have a discussion about HIV testing with their preceptors. Unfortunately, limitations
with student distribution and completion of the voluntary survey reduced the return to
25 surveys over 2 years of collection. Nonetheless, preliminary data on provider
perspectives on routine HIV testing suggests that providers do not know the extent to
which HIV affects the district, and biases lead them to believe that HIV is not a problem
in their patient populations - predominantly Caucasian residents of the Northwest
quadrant of D.C. with private insurance.
According to the D.C. Department of Health 2008 Epidemiology Update, 3% of district residents have
been diagnosed as living with HIV/AIDS. An additional 1/3 to 1/2 of residents living with HIV/AIDS are
unaware of their diagnosis.1,2 Furthermore, data from the D.C. HIV Health Behavior Study3 showed that
75% of newly diagnosed patients had been to at least one medical provider in the past 12 months, but
had not been diagnosed.
One of the most effective prevention methods is to implement HIV screening for all adolescents and
adult patients. According to the CDC September 2006 revised recommendations4 routine opt-out HIV
testing in all adults, adolescents and pregnant women (age 13-64) in health care settings is the
standard of care, and is followed by annual testing if indicated. Building upon these recommendations,
the DC DOH has expanded the age range (13-84) and frequency of testing. In particular, the DC DOH
recommends offering the test annually for the general population and semiannually for MSM regardless
of presence or absence of high-risk behavior.
In 2011, our research group collaborated with the George Washington University Medical School (GW); the
Global Business Coalition on HIV/AIDS, TB and Malaria, the D.C. DOH and the CDC. We developed a survey
that was distributed to D.C. providers, assessing specialty, geographic area of practice, patient demographics,
provider knowledge of HIV testing recommendations, and provider implementation of these recommendations.
A second arm of this project is aimed at involving medical students in the distribution of the survey and thereby
initiating the discussion of routine HIV testing with their mentors (current D.C. providers), increasing both student
and provider knowledge.
In the fall of 2011 and 2012, the survey was distributed to 400 second year medical students to bring to their
mentors in the Ambulatory Care (AC) course, with presentations by peer medical students on current HIV
statistics, recommendations for testing, and the importance of students' role in advocating for this concerning
health issue.
Due to limited return of surveys, we distributed surveys to 120 third year medical students in the spring of 2012
and 2013 during their Ambulatory Medicine month within the Internal Medicine curriculum.
Limited Return of Surveys
25 surveys were returned during the 4 periods of collection from 2011 - 2013, out of a potential 520.
Incorporation of students into the distribution of surveys restricted the number of physicians that
responded. Despite attempts to personally involve students, inform them through peers of the
importance of this issue, and integrate the survey in the AC course, students often will not complete
a survey unless it is mandatory. It is also possible the students did not feel comfortable approaching
their preceptor about HIV while the preceptor was grading the student and the survey may not have
yielded honest results from the physician if the survey was done in the presence of the student. A
future survey will yield greater results if the educational component of the study is removed.
Provider Knowledge of Testing Guidelines
CDC recommendations (Fig. 3A): 95.2% of providers surveyed stated that they were aware of the
CDC guidelines; however, only 35% of these providers were implementing these recommendations.
D.C. Department of Health (Fig. 3B): 68.4% of providers were aware of the D.C. DOH
recommendations; however, of those, only 30.7% were implementing these guidelines.
Fig. 3. Percentages of physicians are who responded as either “Aware and Implementing”, “Aware and Not Implementing” or “Not Aware.”
(A) The CDC recommends that all patients ages 13-64 be tested for HIV in all healthcare settings after the patient is notified and consents
(opt-out testing) and annually for high risk patients. (B) The D.C. DOH recommends that all patients ages 13-84 should be tested annually
and all MSM should be tested every 6 months.
Provider Testing Practices
Fifty-eight percent of providers agreed that it is important to incorporate routine HIV screening in the
medical care of their patients. Surprisingly, 21% (4 out of 25) disagree/strongly disagree that HIV
testing is important to incorporate into routine screening.
Only 4.8% of healthcare providers surveyed reported that they provided HIV tests to 90% or more of
their patients, while 61.9% reported testing 25% of the time or less.
The primary barriers to routine testing cited by providers included:
1) limited time to perform HIV counseling (23.8%)
2) HIV is not an issue for the physician's patient population (23.8%)
3) cost or reimbursement concerns (14.3%)
While 24% specifically stated that there were no barriers.
Fig. 1. Self-reported patient demographics. (A) Estimated percent of patient population of Caucasian, Hispanic/Latino, African American,
Asian/Pacific Islander, Native American/Alaskan Native, Multiracial, or Other. (B) Estimated percent of patient population with Private
Insurance, Medicare, Medicaid, or Self-pay.
The study does not have enough power to make a statistically
significant statement. By removing the educational arm of the
study, we expect to have a greater response rate. There was
an over-representation of private insurance use and
Caucasian races as reported by those surveyed, as well as a
lack of routine HIV testing which may correlate with provider
bias. Further research will help elucidate false assumptions
that physicians make based on their patient's race,
geographic location, and insurance type.
Poster produced by Faculty & Curriculum Support, Georgetown University School of Medicine
We would like to thank Mary Beth Levin (GUSOM), Dr. Catherine Okuliar (GUH), Dr. Eileen Moore (GUH), Dr.
Joesph Timpone (GUH), and Dr. Erica McClaskey (GUH).
Provider Understanding of HIV/AIDS in D.C.
Seventy-two percent of health care providers did not
know the severity of the D.C. HIV/AIDS epidemic. Only
19% correctly stated that all four quadrants of the
district met the UN threshold for a “generalized and
severe” HIV epidemic.
Provider & Patient Demographics
Majority of respondents:
Family Medicine (32%)
Internal Medicine (20%)
Pediatrics (20%)
Patient Demographics: Race (Fig. 1A): On average, providers reported that their patient population
primarily consisted of Caucasian (48%), Hispanic/Latinos (25%), and African American (19%). This
is over-representative of the Caucasian population in D.C.
Patient Demographics: Insurance (Fig. 1B): In terms of reimbursement, 59.6% were covered by
private insurance, 14.1% were covered by Medicaid, 17.1% were covered by Medicare and 7.6%
were self-pay. This is not a representative cross-section of D.C. insurance types, but rather an over-
representation of private insurance.
4 out of 25 were specialists:
2 Hematology Oncology
1 Pulmonology
1 Adolescent Medicine
Fig. 2. Responses to “Which DC quadrant(s) meet the UN criteria for
'generalized and severe' HIV epidemic?” (i.e. HIV prevalence above 1% of the
population). Of the 14 who chose a quadrant (33% answered “Do not know”),
14 selected Southeast, 9 selected Southeast and Northeast, 8 selected
Southeast, Northeast and Southwest, and 4 selected Southeast, Northeast,
Southwest and Northwest.
Physician Responses to
“Which DC Quadrants Meet UN Criteria for HIV
Epidemic?”
Patient Demographics
A B
NW NE
SW SE
8
4 9
14
BA

Mais conteúdo relacionado

Mais procurados

Lisa Barnes PHC6946 Internship Paper
Lisa Barnes PHC6946 Internship PaperLisa Barnes PHC6946 Internship Paper
Lisa Barnes PHC6946 Internship PaperLisa Barnes
 
5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york city5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york citySlidesShare_Foxtrot
 
Adherencia al tarv en am latina y caribe
Adherencia al tarv en am latina y caribeAdherencia al tarv en am latina y caribe
Adherencia al tarv en am latina y caribeRosa Alcayaga
 
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAsCCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAsCanadian Cancer Survivor Network
 
Integrative Health + Data - National Data Institute - Final
Integrative Health + Data - National Data Institute - FinalIntegrative Health + Data - National Data Institute - Final
Integrative Health + Data - National Data Institute - FinalRuthann Russo
 
Situation Critical! New survey reveals COVID 19 continues to disrupt cancer care
Situation Critical! New survey reveals COVID 19 continues to disrupt cancer careSituation Critical! New survey reveals COVID 19 continues to disrupt cancer care
Situation Critical! New survey reveals COVID 19 continues to disrupt cancer careCanadian Cancer Survivor Network
 
Likely stakeholders in the prevention of mother to child transmission of HIV/...
Likely stakeholders in the prevention of mother to child transmission of HIV/...Likely stakeholders in the prevention of mother to child transmission of HIV/...
Likely stakeholders in the prevention of mother to child transmission of HIV/...College of Medicine(University of Malawi)
 
CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...Canadian Cancer Survivor Network
 
Repeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary TestingRepeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary TestingMarija Berzati
 
Capstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AMCapstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AMLindsay Coffman
 
What's New in the Treatment of Gliomas: A Neuro-Oncologist's Perspective
What's New in the Treatment of Gliomas: A Neuro-Oncologist's PerspectiveWhat's New in the Treatment of Gliomas: A Neuro-Oncologist's Perspective
What's New in the Treatment of Gliomas: A Neuro-Oncologist's PerspectiveCanadian Cancer Survivor Network
 
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...Elizabeth kiilu
 

Mais procurados (20)

Lisa Barnes PHC6946 Internship Paper
Lisa Barnes PHC6946 Internship PaperLisa Barnes PHC6946 Internship Paper
Lisa Barnes PHC6946 Internship Paper
 
HIVScreeningApproved
HIVScreeningApprovedHIVScreeningApproved
HIVScreeningApproved
 
5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york city5 myers hiv self-testing in new york city
5 myers hiv self-testing in new york city
 
Poll Shows Improper Use of Antibiotics by Public
Poll Shows Improper Use of Antibiotics by PublicPoll Shows Improper Use of Antibiotics by Public
Poll Shows Improper Use of Antibiotics by Public
 
Adherencia al tarv en am latina y caribe
Adherencia al tarv en am latina y caribeAdherencia al tarv en am latina y caribe
Adherencia al tarv en am latina y caribe
 
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAsCCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
CCSN's Virtual Action Week: Highlights from our Meetings with Alberta MLAs
 
Best Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case ManagementBest Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case Management
 
Integrative Health + Data - National Data Institute - Final
Integrative Health + Data - National Data Institute - FinalIntegrative Health + Data - National Data Institute - Final
Integrative Health + Data - National Data Institute - Final
 
Situation Critical! New survey reveals COVID 19 continues to disrupt cancer care
Situation Critical! New survey reveals COVID 19 continues to disrupt cancer careSituation Critical! New survey reveals COVID 19 continues to disrupt cancer care
Situation Critical! New survey reveals COVID 19 continues to disrupt cancer care
 
Likely stakeholders in the prevention of mother to child transmission of HIV/...
Likely stakeholders in the prevention of mother to child transmission of HIV/...Likely stakeholders in the prevention of mother to child transmission of HIV/...
Likely stakeholders in the prevention of mother to child transmission of HIV/...
 
Lancet oncol 2021
Lancet oncol 2021Lancet oncol 2021
Lancet oncol 2021
 
CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...CanRehab: Improving the systematic identification, management, and treatment ...
CanRehab: Improving the systematic identification, management, and treatment ...
 
Repeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary TestingRepeat HIV Testing at Voluntary Testing
Repeat HIV Testing at Voluntary Testing
 
Clinical Preventive Services - JAMA 4-28-15
Clinical Preventive Services - JAMA 4-28-15Clinical Preventive Services - JAMA 4-28-15
Clinical Preventive Services - JAMA 4-28-15
 
Capstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AMCapstone PPT Koranda 2014 1115AM
Capstone PPT Koranda 2014 1115AM
 
Unmet Basic Needs
Unmet Basic NeedsUnmet Basic Needs
Unmet Basic Needs
 
What's New in the Treatment of Gliomas: A Neuro-Oncologist's Perspective
What's New in the Treatment of Gliomas: A Neuro-Oncologist's PerspectiveWhat's New in the Treatment of Gliomas: A Neuro-Oncologist's Perspective
What's New in the Treatment of Gliomas: A Neuro-Oncologist's Perspective
 
Clin infect dis. 2015-gallant-1878-9
Clin infect dis. 2015-gallant-1878-9Clin infect dis. 2015-gallant-1878-9
Clin infect dis. 2015-gallant-1878-9
 
CROI 2015 FINAL
CROI 2015 FINALCROI 2015 FINAL
CROI 2015 FINAL
 
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
 

Semelhante a HJS_HIVSurveyProject

HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]Mary Beth Levin
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™
 
A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013Hivlife Info
 
Read the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxRead the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxcatheryncouper
 
A New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of AntiretroviralsA New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of Antiretroviralshivlifeinfo
 
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...Real Wellness, LLC
 
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docxvickeryr87
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Mary Beth Levin
 
Welch 2015 Telemedicine and eHealth (1)
Welch 2015 Telemedicine and eHealth (1)Welch 2015 Telemedicine and eHealth (1)
Welch 2015 Telemedicine and eHealth (1)Garry Welch
 
Test and Treat: The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in ContextTest and Treat: The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in ContextOffice of HIV Planning
 
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...CrimsonpublishersCJMI
 
yyoneoka_missedopHPV_2016
yyoneoka_missedopHPV_2016yyoneoka_missedopHPV_2016
yyoneoka_missedopHPV_2016Yukiko Yoneoka
 
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...Efe Clement Abel
 
Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...
Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...
Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...asclepiuspdfs
 
Predicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical TrialsPredicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical TrialsNassim Azzi, MBA
 
Refugee Health, Screening and Data Collection in the Triangle of North Caroli...
Refugee Health, Screening and Data Collection in the Triangle of North Caroli...Refugee Health, Screening and Data Collection in the Triangle of North Caroli...
Refugee Health, Screening and Data Collection in the Triangle of North Caroli...Courtney Hereford
 
Chang et al. BMC Health Services Research (2015) 1527 DOI .docx
Chang et al. BMC Health Services Research  (2015) 1527 DOI .docxChang et al. BMC Health Services Research  (2015) 1527 DOI .docx
Chang et al. BMC Health Services Research (2015) 1527 DOI .docxcravennichole326
 

Semelhante a HJS_HIVSurveyProject (20)

HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013A new options for hiv prevention slides.2013
A new options for hiv prevention slides.2013
 
Read the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxRead the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docx
 
A New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of AntiretroviralsA New Options for HIV Prevention.The Role of Antiretrovirals
A New Options for HIV Prevention.The Role of Antiretrovirals
 
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
 
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
2011; 33 e50–e56WEB PAPERThe ethics of HIV testing an.docx
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]
 
Welch 2015 Telemedicine and eHealth (1)
Welch 2015 Telemedicine and eHealth (1)Welch 2015 Telemedicine and eHealth (1)
Welch 2015 Telemedicine and eHealth (1)
 
Test and Treat: The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in ContextTest and Treat: The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in Context
 
E4P0815_PatientInterest_V6
E4P0815_PatientInterest_V6E4P0815_PatientInterest_V6
E4P0815_PatientInterest_V6
 
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
 
yyoneoka_missedopHPV_2016
yyoneoka_missedopHPV_2016yyoneoka_missedopHPV_2016
yyoneoka_missedopHPV_2016
 
Imjh april-2015-5
Imjh april-2015-5Imjh april-2015-5
Imjh april-2015-5
 
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...
Adherence to Antiretroviral Therapy among HIVPositive Patients in Central Hos...
 
Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...
Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...
Are Primary Care Clinicians Serving Low-Income Patients More Likely to Screen...
 
Predicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical TrialsPredicting Patient Interest and Participation in Clinical Trials
Predicting Patient Interest and Participation in Clinical Trials
 
Refugee Health, Screening and Data Collection in the Triangle of North Caroli...
Refugee Health, Screening and Data Collection in the Triangle of North Caroli...Refugee Health, Screening and Data Collection in the Triangle of North Caroli...
Refugee Health, Screening and Data Collection in the Triangle of North Caroli...
 
Chang et al. BMC Health Services Research (2015) 1527 DOI .docx
Chang et al. BMC Health Services Research  (2015) 1527 DOI .docxChang et al. BMC Health Services Research  (2015) 1527 DOI .docx
Chang et al. BMC Health Services Research (2015) 1527 DOI .docx
 
Navigator_Jessica
Navigator_JessicaNavigator_Jessica
Navigator_Jessica
 

Mais de Mary Beth Levin

HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)Mary Beth Levin
 
HIV prevention conference
HIV prevention conferenceHIV prevention conference
HIV prevention conferenceMary Beth Levin
 
PHIGClinical Skills Workshop
PHIGClinical Skills WorkshopPHIGClinical Skills Workshop
PHIGClinical Skills WorkshopMary Beth Levin
 
9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBLMary Beth Levin
 
Clinical Skills Workshop
Clinical Skills WorkshopClinical Skills Workshop
Clinical Skills WorkshopMary Beth Levin
 
2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange Webinar2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange WebinarMary Beth Levin
 
APHA federal funding for SSPs
APHA federal funding for SSPsAPHA federal funding for SSPs
APHA federal funding for SSPsMary Beth Levin
 
Needle Exchange Factsheet with references
Needle Exchange Factsheet with referencesNeedle Exchange Factsheet with references
Needle Exchange Factsheet with referencesMary Beth Levin
 
060811JointstatementHIV_final_
060811JointstatementHIV_final_060811JointstatementHIV_final_
060811JointstatementHIV_final_Mary Beth Levin
 
ltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re sspsltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re sspsMary Beth Levin
 
Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]Mary Beth Levin
 
PreventionWorks2009-10[1]
PreventionWorks2009-10[1]PreventionWorks2009-10[1]
PreventionWorks2009-10[1]Mary Beth Levin
 
PresentationForUpload[1]
PresentationForUpload[1]PresentationForUpload[1]
PresentationForUpload[1]Mary Beth Levin
 

Mais de Mary Beth Levin (20)

aan
aanaan
aan
 
HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)
 
HIV prevention conference
HIV prevention conferenceHIV prevention conference
HIV prevention conference
 
hesp
hesphesp
hesp
 
PHIGClinical Skills Workshop
PHIGClinical Skills WorkshopPHIGClinical Skills Workshop
PHIGClinical Skills Workshop
 
9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL
 
Clinical Skills Workshop
Clinical Skills WorkshopClinical Skills Workshop
Clinical Skills Workshop
 
2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange Webinar2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange Webinar
 
APHA federal funding for SSPs
APHA federal funding for SSPsAPHA federal funding for SSPs
APHA federal funding for SSPs
 
Pingree letter 12-3-15
Pingree letter 12-3-15Pingree letter 12-3-15
Pingree letter 12-3-15
 
Needle Exchange Factsheet with references
Needle Exchange Factsheet with referencesNeedle Exchange Factsheet with references
Needle Exchange Factsheet with references
 
060811JointstatementHIV_final_
060811JointstatementHIV_final_060811JointstatementHIV_final_
060811JointstatementHIV_final_
 
ltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re sspsltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re ssps
 
Nevada December 17
Nevada December 17Nevada December 17
Nevada December 17
 
pwposter2006-7
pwposter2006-7pwposter2006-7
pwposter2006-7
 
Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]
 
PreventionWorks![2008]
PreventionWorks![2008]PreventionWorks![2008]
PreventionWorks![2008]
 
PreventionWorks2009-10[1]
PreventionWorks2009-10[1]PreventionWorks2009-10[1]
PreventionWorks2009-10[1]
 
PresentationForUpload[1]
PresentationForUpload[1]PresentationForUpload[1]
PresentationForUpload[1]
 
appletreeposter2006
appletreeposter2006appletreeposter2006
appletreeposter2006
 

HJS_HIVSurveyProject

  • 1. HIV Testing Practices Among Providers in Washington D.C. Sofija Degesys, BA1; Isla McClelland, BS1; Christina Hanna, BS1; Kyle Bunker,BS1; Mary Beth Levin, MPH1; Eileen Moore, MD2 Abstract 1Georgetown University School of Medicine, Washington, DC; 2Department of Medicine, Georgetown University Hospital, Washington, Introduction Methods Conclusions References Acknowledgments Georgetown University 1. Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria. Why Aren’t D.C. Doctors Testing for HIV? 2010 Nov 17 <http://www.gbcimpact.org/node/2897>. 2. District of Columbia Department of Health. The District of Columbia HIV/AIDS Epidemiology 2008 Update. 3. District of Columbia Department of Health and George Washington University School of Public Health and Health Services. District of Columbia HIV/AIDS Behavioral Surveillance Summary Report 2008. 4. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings. MMWR Morb Moral Wkly Rep. 2006 Sep 22. Results and Discussion Both the D.C. Department of Health (DOH) and the CDC recommend providers use opt- out HIV testing for all adults, adolescents and pregnant patients. Unfortunately, lack of adherence to these recommendations can have serious consequences as patients unaware of their HIV status will have later diagnoses, correlating with worse medical outcomes. It also leads to the unwitting transmission of HIV to others. A survey was distributed through 520 Georgetown medical students to providers in the D.C. area. The goal of this survey is to assess provider practices, knowledge of guidelines and perceived barriers to routine HIV testing, as well as creating an opportunity for students to have a discussion about HIV testing with their preceptors. Unfortunately, limitations with student distribution and completion of the voluntary survey reduced the return to 25 surveys over 2 years of collection. Nonetheless, preliminary data on provider perspectives on routine HIV testing suggests that providers do not know the extent to which HIV affects the district, and biases lead them to believe that HIV is not a problem in their patient populations - predominantly Caucasian residents of the Northwest quadrant of D.C. with private insurance. According to the D.C. Department of Health 2008 Epidemiology Update, 3% of district residents have been diagnosed as living with HIV/AIDS. An additional 1/3 to 1/2 of residents living with HIV/AIDS are unaware of their diagnosis.1,2 Furthermore, data from the D.C. HIV Health Behavior Study3 showed that 75% of newly diagnosed patients had been to at least one medical provider in the past 12 months, but had not been diagnosed. One of the most effective prevention methods is to implement HIV screening for all adolescents and adult patients. According to the CDC September 2006 revised recommendations4 routine opt-out HIV testing in all adults, adolescents and pregnant women (age 13-64) in health care settings is the standard of care, and is followed by annual testing if indicated. Building upon these recommendations, the DC DOH has expanded the age range (13-84) and frequency of testing. In particular, the DC DOH recommends offering the test annually for the general population and semiannually for MSM regardless of presence or absence of high-risk behavior. In 2011, our research group collaborated with the George Washington University Medical School (GW); the Global Business Coalition on HIV/AIDS, TB and Malaria, the D.C. DOH and the CDC. We developed a survey that was distributed to D.C. providers, assessing specialty, geographic area of practice, patient demographics, provider knowledge of HIV testing recommendations, and provider implementation of these recommendations. A second arm of this project is aimed at involving medical students in the distribution of the survey and thereby initiating the discussion of routine HIV testing with their mentors (current D.C. providers), increasing both student and provider knowledge. In the fall of 2011 and 2012, the survey was distributed to 400 second year medical students to bring to their mentors in the Ambulatory Care (AC) course, with presentations by peer medical students on current HIV statistics, recommendations for testing, and the importance of students' role in advocating for this concerning health issue. Due to limited return of surveys, we distributed surveys to 120 third year medical students in the spring of 2012 and 2013 during their Ambulatory Medicine month within the Internal Medicine curriculum. Limited Return of Surveys 25 surveys were returned during the 4 periods of collection from 2011 - 2013, out of a potential 520. Incorporation of students into the distribution of surveys restricted the number of physicians that responded. Despite attempts to personally involve students, inform them through peers of the importance of this issue, and integrate the survey in the AC course, students often will not complete a survey unless it is mandatory. It is also possible the students did not feel comfortable approaching their preceptor about HIV while the preceptor was grading the student and the survey may not have yielded honest results from the physician if the survey was done in the presence of the student. A future survey will yield greater results if the educational component of the study is removed. Provider Knowledge of Testing Guidelines CDC recommendations (Fig. 3A): 95.2% of providers surveyed stated that they were aware of the CDC guidelines; however, only 35% of these providers were implementing these recommendations. D.C. Department of Health (Fig. 3B): 68.4% of providers were aware of the D.C. DOH recommendations; however, of those, only 30.7% were implementing these guidelines. Fig. 3. Percentages of physicians are who responded as either “Aware and Implementing”, “Aware and Not Implementing” or “Not Aware.” (A) The CDC recommends that all patients ages 13-64 be tested for HIV in all healthcare settings after the patient is notified and consents (opt-out testing) and annually for high risk patients. (B) The D.C. DOH recommends that all patients ages 13-84 should be tested annually and all MSM should be tested every 6 months. Provider Testing Practices Fifty-eight percent of providers agreed that it is important to incorporate routine HIV screening in the medical care of their patients. Surprisingly, 21% (4 out of 25) disagree/strongly disagree that HIV testing is important to incorporate into routine screening. Only 4.8% of healthcare providers surveyed reported that they provided HIV tests to 90% or more of their patients, while 61.9% reported testing 25% of the time or less. The primary barriers to routine testing cited by providers included: 1) limited time to perform HIV counseling (23.8%) 2) HIV is not an issue for the physician's patient population (23.8%) 3) cost or reimbursement concerns (14.3%) While 24% specifically stated that there were no barriers. Fig. 1. Self-reported patient demographics. (A) Estimated percent of patient population of Caucasian, Hispanic/Latino, African American, Asian/Pacific Islander, Native American/Alaskan Native, Multiracial, or Other. (B) Estimated percent of patient population with Private Insurance, Medicare, Medicaid, or Self-pay. The study does not have enough power to make a statistically significant statement. By removing the educational arm of the study, we expect to have a greater response rate. There was an over-representation of private insurance use and Caucasian races as reported by those surveyed, as well as a lack of routine HIV testing which may correlate with provider bias. Further research will help elucidate false assumptions that physicians make based on their patient's race, geographic location, and insurance type. Poster produced by Faculty & Curriculum Support, Georgetown University School of Medicine We would like to thank Mary Beth Levin (GUSOM), Dr. Catherine Okuliar (GUH), Dr. Eileen Moore (GUH), Dr. Joesph Timpone (GUH), and Dr. Erica McClaskey (GUH). Provider Understanding of HIV/AIDS in D.C. Seventy-two percent of health care providers did not know the severity of the D.C. HIV/AIDS epidemic. Only 19% correctly stated that all four quadrants of the district met the UN threshold for a “generalized and severe” HIV epidemic. Provider & Patient Demographics Majority of respondents: Family Medicine (32%) Internal Medicine (20%) Pediatrics (20%) Patient Demographics: Race (Fig. 1A): On average, providers reported that their patient population primarily consisted of Caucasian (48%), Hispanic/Latinos (25%), and African American (19%). This is over-representative of the Caucasian population in D.C. Patient Demographics: Insurance (Fig. 1B): In terms of reimbursement, 59.6% were covered by private insurance, 14.1% were covered by Medicaid, 17.1% were covered by Medicare and 7.6% were self-pay. This is not a representative cross-section of D.C. insurance types, but rather an over- representation of private insurance. 4 out of 25 were specialists: 2 Hematology Oncology 1 Pulmonology 1 Adolescent Medicine Fig. 2. Responses to “Which DC quadrant(s) meet the UN criteria for 'generalized and severe' HIV epidemic?” (i.e. HIV prevalence above 1% of the population). Of the 14 who chose a quadrant (33% answered “Do not know”), 14 selected Southeast, 9 selected Southeast and Northeast, 8 selected Southeast, Northeast and Southwest, and 4 selected Southeast, Northeast, Southwest and Northwest. Physician Responses to “Which DC Quadrants Meet UN Criteria for HIV Epidemic?” Patient Demographics A B NW NE SW SE 8 4 9 14 BA